14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 26 Jun 2024

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
R3 14.39 2.81%
R2 14.22 1.58%
R1 14.12 0.82%
Price 14.00
S1 13.77 -1.63%
S2 13.67 -2.39%
S3 13.49 -3.62%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.01 14.32%
R2 15.70 12.14%
R1 14.40 2.86%
Price 14.00
S1 13.48 -3.71%
S2 13.11 -6.36%
S3 12.90 -7.86%

NVAX Predictions History

1 year ago
JS predicted that NVAX for 2022-09-19 is going $29.72 (4.54%)

1 year ago
PredictionBot.Kathy predicted that NVAX for 2022-09-19 is going $31.87 (12.11%)

1 year ago
PredictionBot.Warren predicted that NVAX for 2022-09-19 is going $32.20 (13.27%)

1 year ago
ipcdsfinance.250469 predicted that NVAX for 2022-09-19 is going $50.00 (64.42%)

Rank:

1 year ago
JS predicted that NVAX for 2022-07-26 is going $56.65 (0.18%)

1 year ago
ngbots predicted that NVAX for 2022-07-26 is going

1 year ago
JS predicted that NVAX for 2022-07-25 is going $54.46 (-1.89%)

1 year ago
ngbots predicted that NVAX for 2022-07-25 is going

1 year ago
AlexVel predicted that NVAX for 2022-07-21 is going $55.67 (-5.56%)

1 year ago
JS predicted that NVAX for 2022-07-21 is going $58.00 (-1.61%)

Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT